Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 28, 2026 07:40 ET | Source: OKYO Pharma LTD

OKYO Pharma Announces Successful Type C Meeting with the FDA

LONDON and NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of...
January 28, 2026 07:27 ET | Source: Research and Markets

Persistent Epithelial Defect Market - A Global and Regional Analysis: Focus on End User and Region, 2025-2035

Dublin, Jan. 28, 2026 (GLOBE NEWSWIRE) -- The "Persistent Epithelial Defect Market - A Global and Regional Analysis: Focus on End User and Region, 2025-2035" has been added to ...
January 27, 2026 09:00 ET | Source: Nextech Systems, Inc.

Nextech Pioneers New Era in Clinical Documentation with Launch of AI-Powered Cora Scribe

Tampa, Fla., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Specialty-specific clinical documentation requires more than a generic, automated note taker to truly improve the charting process. Today, Nextech – an...
January 23, 2026 05:13 ET | Source: Research and Markets

Ophthalmology EMR Software Market - Global Forecast 2026-2032

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Ophthalmology EMR Software Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Ophthalmology EMR Software...
January 22, 2026 11:08 ET | Source: Research and Markets

Ophthalmology PACS Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Dublin, Jan. 22, 2026 (GLOBE NEWSWIRE) -- The "Ophthalmology PACS Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added to ResearchAndMarkets.com's...
January 20, 2026 08:00 ET | Source: SpyGlass Pharma, Inc.

SpyGlass Pharma Announces First Patients Randomized in SGP-005 and SGP-006, Two Registrational Phase III Clinical Trials of Its Novel BIM-IOL System

ALISO VIEJO, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) -- SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational...
January 19, 2026 09:00 ET | Source: BVI Medical, Inc.

BVI Appoints Jim Hollingshead as President & Chief Executive Officer

BVI appoints Jim Hollingshead as President & CEO, succeeding Shervin Korangy, to lead the company’s next phase of global growth and innovation.
January 15, 2026 10:38 ET | Source: Research and Markets

Uveitis Global Clinical Trials Review Report 2025: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

Dublin, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The "Uveitis - Global Clinical Trials Review, 2025" report has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an...
January 15, 2026 08:15 ET | Source: Ocugen

Ocugen Announces Positive Preliminary Phase 2 Data from OCU410 Modifier Gene Therapy for Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Phase 2 (~50% of patients evaluated to date at 12 months) shows 46% lesion growth reduction vs. controlThere are no OCU410-related serious adverse events reported across the Phase 1 and Phase 2...
January 14, 2026 09:51 ET | Source: Research and Markets

$191.2 Million Achromatopsia Market Outlook, 2026-2032, Featuring Adverum Biotechnologies, Homology Medicines, Mattel, REGENXBIO, Sanofi and More

Dublin, Jan. 14, 2026 (GLOBE NEWSWIRE) -- The "Achromatopsia Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering. The Achromatopsia Market is experiencing...